Portfolio: Biotechnology

Helicos Biosciences Corporation
Exited via the public markets

Idenix Pharmaceuticals, Inc.
Anti-HIV and HBV therapy

iPierian
Drug discovery and development company harnessing cellular reprogramming breakthroughs

KaloBios Pharmaceuticals, Inc.
Therapeutic antibody development

Ligand Pharmaceuticals, Inc. (FNA Metabasis Therapeutics, Inc.)
Liver and metabolic diseases linked to liver pathways

Macrogenics, Inc.
Improved therapeutic antibodies